Product/Composition:- | Ipratropium Nebules |
---|---|
Strength:- | 250 mcg/2 mL, 500 mcg/2 mL |
Form:- | Nebulizer Solution |
Reference Brands:- | Atrovent(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Ipratropium Nebules deliver effective bronchodilation for COPD and asthma. Available in 250 mcg and 500 mcg unit-dose solutions, major brands include Atrovent and generics. Pharma B2B platforms streamline bulk procurement of Ipratropium Nebules for hospitals and respiratory care providers focused on managing chronic pulmonary conditions.
Ipratropium Nebules are inhalation solutions used via nebulizer to treat chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. These anticholinergic bronchodilators are commonly available in unit-dose formats like 250 mcg/2 mL and 500 mcg/2 mL, as well as in multi-dose vials (0.025–0.05%). In the US, Ipratropium is marketed as Atrovent by Boehringer Ingelheim and via generics by Teva and Nephron. In the EU, Atrovent and its equivalents are produced by Sandoz, Teva, and Stada. Pharma B2B platforms ensure consistent supply of Ipratropium Nebules for hospitals, clinics, and respiratory therapy centers treating obstructive airway disorders.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications